AI for Merger Models: Claude Tools for M&A Accretion/Dilution and Pro Forma Analysis
How investment bankers use Claude for merger modeling: accretion/dilution analysis, purchase price allocation, goodwill calculation, D&A step-up, deal structure comparison (cash vs stock vs mixed), synergy analysis, and contribution analysis.
Merger Models and AI
Merger modeling (sometimes called accretion/dilution analysis or pro forma combination analysis) is the core analytical tool for evaluating acquisitions from the acquirer's perspective. It tests whether a deal enhances or reduces EPS, computes the combined entity's credit profile, and models synergy impact. Claude with ClaudeFinLab builds complete merger models from deal terms, allocates purchase price, and stress-tests the accretion across different deal structures.
Accretion/Dilution Analysis
- "Accretion/dilution for an all-stock deal: Acquirer EPS $3.20, shares outstanding 84M. Target net income $28M, purchase price $480M. Exchange ratio: $480M / acquirer share price $38 = 12.63M new shares issued. New share count: 84M + 12.63M = 96.63M shares. Combined net income: acquirer NI $268.8M + target NI $28M = $296.8M. But: add back D&A step-up ($18M pre-tax → $13.5M after-tax at 25% tax rate → subtract). And add synergies (Year 1: $15M pre-tax → $11.25M after-tax). Pro forma EPS: $296.8M − $13.5M + $11.25M = $294.55M / 96.63M = $3.05. Accretion/dilution: ($3.05 − $3.20) / $3.20 = -4.7% dilutive."
- "Accretion/dilution for a cash deal: same acquisition but funded 50% cash ($240M) at 6.5% pre-tax cost + 50% debt ($240M) at 7.2% pre-tax cost. After-tax financing cost: ($240M × 6.5% + $240M × 7.2%) × (1 − 25%) = ($15.6M + $17.28M) × 75% = $24.66M annual. Combined NI: $296.8M − $24.66M (financing) − $13.5M (D&A step-up) + $11.25M (synergies) = $269.89M / 84M shares (no dilution from new shares) = $3.21. Accretion: +0.3% — modestly accretive."
- "Breakeven analysis: at what price per share (all-stock deal) is the transaction EPS-neutral? If target NI = $28M + $11.25M synergies − $13.5M D&A step-up = $25.75M incremental. At neutral EPS $3.20: new shares needed = $25.75M / $3.20 = 8.05M shares. Share price = $480M / 8.05M = $59.63 (vs current $38). Acquirer would need to be at $59.63 for the deal to be EPS-neutral. What is the implied premium?"
Purchase Price Allocation (PPA)
- "Purchase price allocation for $480M acquisition: Target book value net assets $85M. Step 1 — identify and value tangible assets at fair value: PP&E step-up from $42M book to $58M fair value (+$16M). Inventory step-up from $28M to $34M (+$6M). Total tangible step-up $22M. Step 2 — identified intangibles: customer relationships $65M (useful life 12 years → $5.4M annual amortization); technology IP $28M (5 years → $5.6M); trade name $12M (indefinite life — no amortization). Step 3 — goodwill = $480M − ($85M + $22M + $65M + $28M + $12M) = $268M."
- "D&A step-up impact on pro forma earnings: identified intangible amortization: customer relationships $5.4M + technology $5.6M = $11M/year. PP&E step-up depreciation: $16M / 10 years = $1.6M/year. Inventory step-up ($6M) expensed in Year 1 only (COGS). Total D&A step-up Year 1: $11M + $1.6M + $6M = $18.6M. Years 2+: $12.6M (no inventory step-up recurrence). After-tax impact Year 1: $18.6M × 0.75 = $13.95M earnings reduction."
- "Goodwill impairment sensitivity: goodwill $268M allocated to a single reporting unit. Reporting unit fair value at acquisition: $480M (purchase price). If enterprise value declines 30% to $336M, and reporting unit carrying value is $480M → impairment test fails ($336M < $480M carrying). Impairment charge: $480M − $336M = $144M (non-cash). Impact on equity: reduces retained earnings $144M. Impact on EPS: $144M / 84M shares = $1.71 EPS charge. What leverage covenant metric (debt/EBITDA) is affected if the impairment reduces EBITDA by being in the covenant definition?"
Deal Structure Analysis
- "Cash vs stock vs mixed deal comparison: $480M acquisition. Option A: 100% cash (debt-financed $240M + existing cash $240M). Option B: 100% stock (exchange ratio 12.63M new shares). Option C: 60/40 mixed ($288M cash + $192M stock = 5.05M new shares). Compare: (1) EPS impact of each structure; (2) leverage post-close; (3) earnings retention (cash has interest cost, stock has dilution, mixed has both); (4) tax treatment (cash is taxable to target shareholders; stock may be tax-free under IRC §368)."
- "Collar structure in stock deals: in volatile markets, fixed exchange ratios create price risk for both parties. A collar protects both sides: fixed ratio only if acquirer stock stays in a $34-$42 band around $38. Below $34: ratio adjusts so target shareholders receive value = $34 × base ratio / $38. Above $42: ratio adjusts downward. Model the target shareholder's proceeds at acquirer prices: $28, $34, $38, $42, $48. When does the collar provide protection and when does it leave price risk?"
Synergy Analysis
- "Cost synergy analysis: combined entity will reduce headcount by 180 people (target redundant back-office functions). Average total comp per person $85K (salary + benefits). Annual savings: 180 × $85K = $15.3M. One-time restructuring costs: 180 × $25K severance + integration costs $8.4M = $12.9M. Revenue synergies (Year 3): cross-sell acquirer products to target customers — expected $8M incremental revenue at 40% margin = $3.2M. Total synergies Year 3: $15.3M cost + $3.2M revenue = $18.5M. NPV of synergies at 10% WACC over 5 years: PV = $18.5M / 10% = $185M (perpetuity). This represents 38.5% of the $480M purchase price — a reasonable synergy assumption?"
- "Synergy risk-adjusted value: cost synergies have higher confidence (85%) than revenue synergies (40%). Risk-adjusted synergy value: $15.3M × 85% + $3.2M × 40% = $13.0M + $1.28M = $14.28M risk-adjusted annual. Synergy NPV at 10%: $142.8M. The acquirer pays $480M and gets $142.8M of risk-adjusted synergies = 29.8% of price. Maximum price a buyer should pay to avoid synergy overpayment: standalone value + synergies NPV = (target standalone value $380M) + $142.8M = $522.8M. So $480M is within range, assuming the standalone $380M valuation holds."
Contribution Analysis
- "Contribution analysis for swap ratio negotiation: combined entity — acquirer contributes 78% of revenue, 81% of EBITDA, 76% of book value, 74% of net income. Target contributes 22%, 19%, 24%, 26%. Average contribution to value drivers: ~23% for target. If the deal implies target shareholders own 13.1% of combined (12.63M / 96.63M), are they getting fair value for their 23% contribution? This creates negotiating tension — target will argue for a higher exchange ratio."
M&A advisory note: Merger model analysis is a tool for evaluating potential transactions. Investment decisions, fairness opinions, and board recommendations require licensed financial advisors, legal counsel, and compliance with SEC proxy rules, fiduciary duties, and applicable takeover regulations. AI-built merger models should be independently verified before use in board presentations or regulatory filings.